KYTHERA Biopharmaceuticals (FRA:KYT) YoY Rev. per Sh. Growth : 0.00% (As of Jun. 2015)

View and export this data going back to . Start your Free Trial

What is KYTHERA Biopharmaceuticals YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. KYTHERA Biopharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2015 was 0.00%.

KYTHERA Biopharmaceuticals's Revenue per Share for the three months ended in Jun. 2015 was €0.01.

KYTHERA Biopharmaceuticals YoY Rev. per Sh. Growth Historical Data

The historical data trend for KYTHERA Biopharmaceuticals's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KYTHERA Biopharmaceuticals YoY Rev. per Sh. Growth Chart

KYTHERA Biopharmaceuticals Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

YoY Rev. per Sh. Growth

186.49

-56.84

-100.00

KYTHERA Biopharmaceuticals Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial														-	-	-	-	-

KYTHERA Biopharmaceuticals YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

KYTHERA Biopharmaceuticals's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2014 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2014 )
=	(Revenue per Share (A: Dec. 2014 )	-	Revenue per Share (A: Dec. 2013 ))	/	\| Revenue per Share (A: Dec. 2013 ) \|
=	(0	-	0)	/	\| 0 \|
=	N/A %

KYTHERA Biopharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2015 is calculated as:

	YoY Rev. per Sh. Growth (Q: Jun. 2015 )
=	(Revenue per Share (Q: Jun. 2015 )	-	Revenue per Share (Q: Jun. 2014 ))	/	\| Revenue per Share (Q: Jun. 2014 )) \|
=	(0.01	-	0)	/	\| 0 \|
=	N/A %

KYTHERA Biopharmaceuticals YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of KYTHERA Biopharmaceuticals's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

KYTHERA Biopharmaceuticals (FRA:KYT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KYTHERA Biopharmaceuticals Inc (FRA:KYT) » Definitions » YoY Rev. per Sh. Growth

Traded in Other Exchanges

N/A

Address

Website

http://www.kytherabiopharma.com

KYTHERA Biopharmaceuticals Inc was incorporated in Delaware in June 2004 under the name Dermion, Inc. It commenced operations in August 2005, and it changed its name to AESTHERx, Inc. In July 2006, it changed its name to KYTHERA Biopharmaceuticals, Inc. It is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. The Company's objective is to develop first-in-class, prescription aesthetic products using an approach that relies on the scientific rigor of biotechnology to address unmet needs in the rapidly-growing market for aesthetic medicine. The Company's initial focus is on the facial aesthetics market, which comprises the majority of the aesthetic medicine market. The Company's product candidate, ATX-101, is a potential first-in-class, injectable drug in late stage clinical development for the reduction of submental fat, which commonly presents as an undesirable double chin. Based on clinical trials conducted to date, ATX-101 has exhibited significant, meaningful and long-lasting results in the reduction of submental fat.

KYTHERA Biopharmaceuticals (FRA:KYT) Headlines

No Headlines